The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Lower GI Series-Global Market Insights and Sales Trends 2024
Synopsis
A lower GI series is a procedure in which a doctor uses x-rays and a chalky liquid called bariumto view your large intestine. The barium will make your large intestine more visible on an x-ray. The two types of lower GI series are a single-contrast lower GI series, which uses only barium and a double-contrast or air-contrast lower GI series, which uses both barium and air for a clearer view of your large intestine.
The global Lower GI Series market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Lower GI Series in various end use industries. The expanding demands from the Hospital, Clinic and Other,, are propelling Lower GI Series market. Double-Contrast, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Single-Contrast segment is estimated at % CAGR for the next seven-year period.
A lower GI series can help a doctor find the cause of bleeding from anus, changes in bowel activity, chronic diarrhea, pain in abdomen and unexplained weight loss.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lower GI Series, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lower GI Series market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lower GI Series market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lower GI Series sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lower GI Series covered in this report include Eisai, Cadila Pharmaceuticals, Purdue Pharma, Peacehealth, Novadaq, Astrazeneca and Ironwood Pharmaceuticals, etc.
The global Lower GI Series market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eisai
Cadila Pharmaceuticals
Purdue Pharma
Peacehealth
Novadaq
Astrazeneca
Ironwood Pharmaceuticals
Global Lower GI Series market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lower GI Series market, Segment by Type:
Double-Contrast
Single-Contrast
Global Lower GI Series market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Lower GI Series companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A lower GI series is a procedure in which a doctor uses x-rays and a chalky liquid called bariumto view your large intestine. The barium will make your large intestine more visible on an x-ray. The two types of lower GI series are a single-contrast lower GI series, which uses only barium and a double-contrast or air-contrast lower GI series, which uses both barium and air for a clearer view of your large intestine.
The global Lower GI Series market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Lower GI Series in various end use industries. The expanding demands from the Hospital, Clinic and Other,, are propelling Lower GI Series market. Double-Contrast, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Single-Contrast segment is estimated at % CAGR for the next seven-year period.
A lower GI series can help a doctor find the cause of bleeding from anus, changes in bowel activity, chronic diarrhea, pain in abdomen and unexplained weight loss.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lower GI Series, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lower GI Series market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lower GI Series market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lower GI Series sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lower GI Series covered in this report include Eisai, Cadila Pharmaceuticals, Purdue Pharma, Peacehealth, Novadaq, Astrazeneca and Ironwood Pharmaceuticals, etc.
The global Lower GI Series market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eisai
Cadila Pharmaceuticals
Purdue Pharma
Peacehealth
Novadaq
Astrazeneca
Ironwood Pharmaceuticals
Global Lower GI Series market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lower GI Series market, Segment by Type:
Double-Contrast
Single-Contrast
Global Lower GI Series market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Lower GI Series companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Lower GI Series
1.1 Lower GI Series Market Overview
1.1.1 Lower GI Series Product Scope
1.1.2 Lower GI Series Market Status and Outlook
1.2 Global Lower GI Series Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Lower GI Series Market Size by Region (2018-2029)
1.4 Global Lower GI Series Historic Market Size by Region (2018-2023)
1.5 Global Lower GI Series Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Lower GI Series Market Size (2018-2029)
1.6.1 North America Lower GI Series Market Size (2018-2029)
1.6.2 Europe Lower GI Series Market Size (2018-2029)
1.6.3 Asia-Pacific Lower GI Series Market Size (2018-2029)
1.6.4 Latin America Lower GI Series Market Size (2018-2029)
1.6.5 Middle East & Africa Lower GI Series Market Size (2018-2029)
2 Lower GI Series Market by Type
2.1 Introduction
2.1.1 Double-Contrast
2.1.2 Single-Contrast
2.2 Global Lower GI Series Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Lower GI Series Historic Market Size by Type (2018-2023)
2.2.2 Global Lower GI Series Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Lower GI Series Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Lower GI Series Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Lower GI Series Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Lower GI Series Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Lower GI Series Revenue Breakdown by Type (2018-2029)
3 Lower GI Series Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Other
3.2 Global Lower GI Series Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Lower GI Series Historic Market Size by Application (2018-2023)
3.2.2 Global Lower GI Series Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Lower GI Series Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Lower GI Series Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Lower GI Series Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Lower GI Series Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Lower GI Series Revenue Breakdown by Application (2018-2029)
4 Lower GI Series Competition Analysis by Players
4.1 Global Lower GI Series Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lower GI Series as of 2022)
4.3 Date of Key Players Enter into Lower GI Series Market
4.4 Global Top Players Lower GI Series Headquarters and Area Served
4.5 Key Players Lower GI Series Product Solution and Service
4.6 Competitive Status
4.6.1 Lower GI Series Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eisai
5.1.1 Eisai Profile
5.1.2 Eisai Main Business
5.1.3 Eisai Lower GI Series Products, Services and Solutions
5.1.4 Eisai Lower GI Series Revenue (US$ Million) & (2018-2023)
5.1.5 Eisai Recent Developments
5.2 Cadila Pharmaceuticals
5.2.1 Cadila Pharmaceuticals Profile
5.2.2 Cadila Pharmaceuticals Main Business
5.2.3 Cadila Pharmaceuticals Lower GI Series Products, Services and Solutions
5.2.4 Cadila Pharmaceuticals Lower GI Series Revenue (US$ Million) & (2018-2023)
5.2.5 Cadila Pharmaceuticals Recent Developments
5.3 Purdue Pharma
5.3.1 Purdue Pharma Profile
5.3.2 Purdue Pharma Main Business
5.3.3 Purdue Pharma Lower GI Series Products, Services and Solutions
5.3.4 Purdue Pharma Lower GI Series Revenue (US$ Million) & (2018-2023)
5.3.5 Peacehealth Recent Developments
5.4 Peacehealth
5.4.1 Peacehealth Profile
5.4.2 Peacehealth Main Business
5.4.3 Peacehealth Lower GI Series Products, Services and Solutions
5.4.4 Peacehealth Lower GI Series Revenue (US$ Million) & (2018-2023)
5.4.5 Peacehealth Recent Developments
5.5 Novadaq
5.5.1 Novadaq Profile
5.5.2 Novadaq Main Business
5.5.3 Novadaq Lower GI Series Products, Services and Solutions
5.5.4 Novadaq Lower GI Series Revenue (US$ Million) & (2018-2023)
5.5.5 Novadaq Recent Developments
5.6 Astrazeneca
5.6.1 Astrazeneca Profile
5.6.2 Astrazeneca Main Business
5.6.3 Astrazeneca Lower GI Series Products, Services and Solutions
5.6.4 Astrazeneca Lower GI Series Revenue (US$ Million) & (2018-2023)
5.6.5 Astrazeneca Recent Developments
5.7 Ironwood Pharmaceuticals
5.7.1 Ironwood Pharmaceuticals Profile
5.7.2 Ironwood Pharmaceuticals Main Business
5.7.3 Ironwood Pharmaceuticals Lower GI Series Products, Services and Solutions
5.7.4 Ironwood Pharmaceuticals Lower GI Series Revenue (US$ Million) & (2018-2023)
5.7.5 Ironwood Pharmaceuticals Recent Developments
6 North America
6.1 North America Lower GI Series Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Lower GI Series Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Lower GI Series Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Lower GI Series Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Lower GI Series Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Lower GI Series Market Dynamics
11.1 Lower GI Series Industry Trends
11.2 Lower GI Series Market Drivers
11.3 Lower GI Series Market Challenges
11.4 Lower GI Series Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
